Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Diabetology International
|
January 4, 2019
Negative effect of a previous diagnosis of diabetes on quality of life in a Japanese population: The Gifu Diabetes Study
Yukiko Nonoyama, Mayumi Yamamoto, Shino Oba, et al.
Journal of Pharmacological Sciences
|
March 2, 2011
SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
Biological & Pharmaceutical Bulletin
|
March 1, 2021
Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca<sup>2+</sup> Channels, on Visceral Pain in Mice
Maho Tsubota, Kazuki Matsui, Saaya Fukushi, et al.
Pharmacology
|
February 4, 2012
Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 17, 2015
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib
Yasuhiro Tsume, Susumu Takeuchi, Kazuki Matsui, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 13, 2021
Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy
Kazuki Matsui, Tomoya Nakagawa, Tomonori Okumura, et al.
International Journal of Pharmaceutics
|
December 23, 2022
Lowly-buffered biorelevant dissolution testing is not necessarily biopredictive of human bioequivalence study outcome: Relationship between dissolution and pharmacokinetics
Kazuki Matsui, Katsuki Nakamichi, Masatoshi Nakatani, et al.
Journal of Cardiovascular Pharmacology
|
January 14, 2012
SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2007
RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking
Kazuki Matsui, Yoshihiro Sasaki, Takayoshi Komatsu, et al.
European Journal of Pharmacology
|
September 27, 2005
Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits
Kazuto Yamada, Kazuki Matsui, Shoji Ogawa, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Diabetology International
|
January 4, 2019
Negative effect of a previous diagnosis of diabetes on quality of life in a Japanese population: The Gifu Diabetes Study
Yukiko Nonoyama, Mayumi Yamamoto, Shino Oba, et al.
Journal of Pharmacological Sciences
|
March 2, 2011
SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
Biological & Pharmaceutical Bulletin
|
March 1, 2021
Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca<sup>2+</sup> Channels, on Visceral Pain in Mice
Maho Tsubota, Kazuki Matsui, Saaya Fukushi, et al.
Pharmacology
|
February 4, 2012
Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 17, 2015
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib
Yasuhiro Tsume, Susumu Takeuchi, Kazuki Matsui, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 13, 2021
Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy
Kazuki Matsui, Tomoya Nakagawa, Tomonori Okumura, et al.
International Journal of Pharmaceutics
|
December 23, 2022
Lowly-buffered biorelevant dissolution testing is not necessarily biopredictive of human bioequivalence study outcome: Relationship between dissolution and pharmacokinetics
Kazuki Matsui, Katsuki Nakamichi, Masatoshi Nakatani, et al.
Journal of Cardiovascular Pharmacology
|
January 14, 2012
SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats
Tetsuro Nariai, Katsuya Fujita, Masaya Mori, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2007
RNAi gene silencing using cerasome as a viral-size siRNA-carrier free from fusion and cross-linking
Kazuki Matsui, Yoshihiro Sasaki, Takayoshi Komatsu, et al.
European Journal of Pharmacology
|
September 27, 2005
Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits
Kazuto Yamada, Kazuki Matsui, Shoji Ogawa, et al.
Page
of 5